Suppr超能文献

细胞外超氧化物歧化酶在特发性肺纤维化/普通型间质性肺炎中具有高度特异性定位。

Extracellular superoxide dismutase has a highly specific localization in idiopathic pulmonary fibrosis/usual interstitial pneumonia.

作者信息

Kinnula V L, Hodgson U A, Lakari E K, Tan R J, Sormunen R T, Soini Y M, Kakko S J, Laitinen T H, Oury T D, Pääkkö P K

机构信息

University of Helsinki, Department of Medicine, PO Box 22, 00014 Helsinki, Finland.

出版信息

Histopathology. 2006 Jul;49(1):66-74. doi: 10.1111/j.1365-2559.2006.02470.x.

Abstract

AIMS

Recent studies suggest the importance of oxidant stress in the progression of pulmonary fibrosis. The aim of this study was to investigate extracellular superoxide dismutase (ECSOD), the major antioxidant enzyme of the extracellular matrix of human lung, in biopsy-proven idiopathic pulmonary fibrosis (IPF) related to usual interstitial pneumonia (UIP).

METHODS AND RESULTS

Fibrotic areas and fibroblastic foci in UIP lungs were notable for absence of ECSOD by immunohistochemistry. Western blotting showed significantly lowered immunoreactivity of ECSOD in fibrotic compared with non-fibrotic areas of the diseased lung. The only cell type that showed intense ECSOD positivity in UIP was the interstitial mast cell. In order to investigate the mechanism for ECSOD depletion in fibrotic areas, alveolar epithelial cells were exposed to tumour necrosis factor-alpha and transforming growth factor (TGF)-beta1; TGF-beta suggested a trend towards decreased synthesis. Patients with UIP were also assessed to determine whether this disease is associated with a naturally occurring mutation in ECSOD (Arg213Gly) which leads to a loss of tissue binding of ECSOD. No significant differences could be found in the allele or genotype frequencies of this polymorphism between 63 UIP patients and 61 control subjects.

CONCLUSION

Overall, consistent with several other antioxidant enzymes, ECSOD is very low in fibrotic areas of UIP, which may further increase the oxidant burden in this disease.

摘要

目的

近期研究表明氧化应激在肺纤维化进展中具有重要作用。本研究旨在调查细胞外超氧化物歧化酶(ECSOD),即人肺细胞外基质的主要抗氧化酶,在经活检证实的与普通间质性肺炎(UIP)相关的特发性肺纤维化(IPF)中的情况。

方法与结果

通过免疫组织化学方法发现,UIP肺中的纤维化区域和成纤维细胞灶均无ECSOD。蛋白质印迹法显示,与患病肺的非纤维化区域相比,纤维化区域中ECSOD的免疫反应性显著降低。在UIP中唯一显示强烈ECSOD阳性的细胞类型是间质肥大细胞。为了研究纤维化区域中ECSOD耗竭的机制,将肺泡上皮细胞暴露于肿瘤坏死因子-α和转化生长因子(TGF)-β1;TGF-β显示出合成减少的趋势。还对UIP患者进行了评估,以确定该疾病是否与ECSOD(Arg213Gly)的自然发生突变相关,该突变导致ECSOD的组织结合丧失。在63例UIP患者和61例对照受试者之间,该多态性的等位基因或基因型频率未发现显著差异。

结论

总体而言,与其他几种抗氧化酶一致,UIP纤维化区域中的ECSOD非常低,这可能会进一步增加该疾病中的氧化应激负担。

相似文献

2
Oxidative stress contributes to the induction and persistence of TGF-β1 induced pulmonary fibrosis.
Int J Biochem Cell Biol. 2011 Aug;43(8):1122-33. doi: 10.1016/j.biocel.2011.04.005. Epub 2011 Apr 14.
3
Cell-specific regulation of gamma-glutamylcysteine synthetase in human interstitial lung diseases.
Hum Pathol. 2004 Jul;35(7):832-9. doi: 10.1016/j.humpath.2004.03.010.
5
Active remodeling in idiopathic interstitial pneumonias: evaluation of collagen types XII and XIV.
J Histochem Cytochem. 2006 Jun;54(6):693-700. doi: 10.1369/jhc.5A6835.2006. Epub 2006 Feb 6.
7
Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia.
Respiration. 2007;74(2):159-69. doi: 10.1159/000097133. Epub 2006 Nov 14.
9
HSP47 in lung fibroblasts is a predictor of survival in fibrotic nonspecific interstitial pneumonia.
Respir Med. 2010 Jun;104(6):895-901. doi: 10.1016/j.rmed.2010.01.011. Epub 2010 Feb 2.

引用本文的文献

1
2
Role of Essential Oils and Antioxidants in the Treatment of Fibrosis.
Curr Drug Res Rev. 2025;17(1):76-89. doi: 10.2174/0125899775271616231205111827.
3
Decoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis.
Eur Respir J. 2025 May 22;65(5). doi: 10.1183/13993003.02418-2024. Print 2025 May.
5
Lung-Targeted Delivery of Dimethyl Fumarate Promotes the Reversal of Age-Dependent Established Lung Fibrosis.
Antioxidants (Basel). 2022 Feb 28;11(3):492. doi: 10.3390/antiox11030492.
6
Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis.
Front Pharmacol. 2022 Jan 21;12:794997. doi: 10.3389/fphar.2021.794997. eCollection 2021.
8
The ageing lung under stress.
Eur Respir Rev. 2020 Jul 7;29(156). doi: 10.1183/16000617.0126-2020. Print 2020 Jun 30.
9
The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice.
BMC Pulm Med. 2020 Apr 29;20(1):112. doi: 10.1186/s12890-020-1142-x.
10
Redox Imbalance in Idiopathic Pulmonary Fibrosis: A Role for Oxidant Cross-Talk Between NADPH Oxidase Enzymes and Mitochondria.
Antioxid Redox Signal. 2019 Nov 10;31(14):1092-1115. doi: 10.1089/ars.2019.7742. Epub 2019 Apr 5.

本文引用的文献

2
Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy.
Am J Respir Crit Care Med. 2005 Aug 15;172(4):417-22. doi: 10.1164/rccm.200501-017PP. Epub 2005 May 13.
4
Differential expression of superoxide dismutases in lung cancer.
Am J Clin Pathol. 2004 Sep;122(3):395-404. doi: 10.1309/A45Q-HB0Q-RRX6-CT9A.
5
Redistribution of pulmonary EC-SOD after exposure to asbestos.
J Appl Physiol (1985). 2004 Nov;97(5):2006-13. doi: 10.1152/japplphysiol.00480.2004. Epub 2004 Aug 6.
6
Cell-specific regulation of gamma-glutamylcysteine synthetase in human interstitial lung diseases.
Hum Pathol. 2004 Jul;35(7):832-9. doi: 10.1016/j.humpath.2004.03.010.
7
Expression of the thioredoxin system in interstitial lung disease.
J Pathol. 2003 Nov;201(3):363-70. doi: 10.1002/path.1435.
8
Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase.
Free Radic Biol Med. 2003 Oct 1;35(7):763-71. doi: 10.1016/s0891-5849(03)00402-7.
9
Extracellular superoxide dismutase in biology and medicine.
Free Radic Biol Med. 2003 Aug 1;35(3):236-56. doi: 10.1016/s0891-5849(03)00275-2.
10
Superoxide dismutases in the lung and human lung diseases.
Am J Respir Crit Care Med. 2003 Jun 15;167(12):1600-19. doi: 10.1164/rccm.200212-1479SO.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验